In the consumer protection lawsuit, the Federal Trade Commission and the attorneys general from three states are suing the World Professional Association for Transgender Health, WPATH. The lawsuit alleges WPATH members betrayed their Hippocratic Oath by putting profit ahead of their patients, who are children, based on a promise they were helping them through difficult times.
The states who are co-plaintiffs in the lawsuit are Alaska, Iowa, Nebraska, and Texas.
Dr. Quentin Van Meter, a member of the American College of Pediatricians, told “Washington Watch” the FTC is involved because it alleges numerous parties stood to benefit financially in the insurance industry, medical field, and pharmaceutical industry.
“The promise to the parents, and the patients,” Van Meter said, “are that all of their mental health issues are essentially due to their gender confusion, not the mental health issues creating the gender confusion.”
That “promise” included a medical-based assurance that the “transition” from boy to girl, or girl to boy, would improve their mental health and end any potential for suicide in the future.
People who have undergone such procedures, such as detransitioner Chloe Cole, have said her worried parents were given the “live boy or dead girl” warning from doctors that led to her undergoing a mastectomy as a teenager.
Whereas transgender ideology has taken off in recent years, affecting everything from children’s books and state laws to high school athletics, the FTC lawsuit maintains WPATH committed fraud through its profit-driven motive that counseled children and parents, and prescribed body-changing hormones.
"It is it is actually a practice of promising something to the patient which does not really exist," Van Meter warned.
In response to the FTC lawsuit, WPATH claims it’s a victim of an overreaching federal government and said it’s defending its First Amendment rights.
“The federal government’s continued campaign to undermine gender-affirming care by attacking the First Amendment should be cause for concern among the broader medical community,” an spokesman for WPATH said in a statement.
